Kalorama Information is the authoritative market research source for the diagnostics industry. Find essential insights, market shares, sales segmentation and projections for in vitro diagnostics (IVD) and medical imaging markets. Kalorama’s reports, including The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 13th edition, analyze the global in vitro diagnostics market, now worth approximately $83.3 billion. Our diagnostics market research covers trends in health care service delivery, including the rapidly advancing diagnostic laboratory technology industry. Discover emerging diagnostics market niches in our updated reports that present the trends, technologies, customer needs, and major suppliers currently shaping the diagnostics industry.
Molecular Assays
Point-of-Care
Immunoassays
Infectious Disease
Clinical Chemistry
Oncology/Hematology
Lab Testing Services
Medical Imaging
- Display 30 Products per page
Published: August 22, 2022 | Price: $0.00 – $10,000.00
The search for the next large-scale emerging disease was on before the COVID-19 pandemic. Respiratory diseases were among those suggested by Kalorama Information and other outlets and medical associations as possibilities for the next threat. The search is constant, and is by no means limited to respiratory epidemics. As the recent monkeypox concern has demonstrated, little-known pathogens can emerge and become large health threats. This necessitates the development of tests at laboratories. For business planners, it’s worthwhile to have a...Published: September 2, 2022 | Price: $0.00 – $12,000.00
The global in vitro diagnostic (IVD) industry incorporates a sizable contract manufacturing segment that supplies a full range of reagents and test kits, instruments and systems, and testing accessories. Already a multi-billion dollar market, this segment is well positioned to generate favorable long-term growth, as detailed in this report, The Market for Contract Manufacturing in IVD. Most leading worldwide of producers of proprietary IVD systems will increase their reliance on outside contractors as a cost-effective means to: expand existing product...Published: June 7, 2018 | Price: $99.00 – $198.00
A summary of major trends in the IVD industry, from harmonization to Cardiac marker testing.Published: February 1, 2011 | Price: $150.00 – $300.00
This report covers the U.S. market for Picture Archiving and Communication Systems (PACS) and provides an overview of imaging systems, EMR and PACS technologies and products. The report describes the industry, its relationship to various healthcare channels, and the trends for the future. The report addresses some of the issues surrounding IT in healthcare and how the PACS arena is affected by these issues. While Kalorama Information has studied EMR markets in great detail in other reports, this report does...Published: March 1, 2011 | Price: $150.00 – $300.00
This report The World Market for Molecular Diagnostics: Potential and Reality, What's Hot and What's Not estimates the market for molecular diagnostics and provides a realistic look at the role of molecular testing and its future in various market segments. Kalorama Information's lead diagnostics analyst Shara Rosen, R.T., MBA, also reviews the competitors in the market and their latest moves. There have been many predictions made about a molecular revolution in diagnostics. Indeed some are now taking place, while other...Published: April 1, 2011 | Price: $150.00 – $300.00
Even though slightly more than half of the US population is female, medical research historically has neglected the health needs of women, other than reproductive issues. However, during the past two decades, there have been major changes in government and private support of women’s health research -- in policies, regulations, and the organization of research efforts. In a recent Institute of Medicine (IOM) report, the Washington DC-based institute found that women’s health research has contributed to significant progress over the...Published: June 1, 2011 | Price: $150.00 – $300.00
There is much discussion about emerging markets in in vitro diagnostics, especially the BRIC nations - Brazil, Russia, India and China. Which companies have been successful in these markets and how have they accomplished it? What kind of realistic growth can marketers expect by selling products in these areas? This report is intended to provide an overview of trends and developments in the IVD industry as it applies to emerging markets and the BRIC countries in particular. A Realistic Look...Published: July 1, 2011 | Price: $150.00 – $300.00
A hospital-acquired infection (HAI)is a new infection that develops in a patient during hospitalization. It is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, so infections incubating, but not clinically apparent, at admission are excluded. This type of infection is also known as a nosocomial infection (or more generically healthcare-associated infections). The industry has responded with a variety of testing and treatment products. This report, Hospital-Acquired Infections: Diagnostic Markets and Testing Developments,...Published: October 1, 2011 | Price: $150.00 – $300.00
The World Health Organization has identified a group of diseases that are the world's most pressing health problems. This represents an opportunity for test manufacturers, particularly in POC testing. Because of their ability to deliver fast results at the point of care, rapid testing is a focus area of healthcare providers and payors in infectious disease prevention. Kalorama Information has been reporting on the rapid test area for several years and has identified the segments with the fastest growth, and...Published: November 1, 2011 | Price: $150.00 – $300.00
Radiography includes mammography, computed tomography, traditional x-ray and digital x-ray. These imaging procedures are affected by a number of factors: advances in technology, consumer expectations for healthcare, declining reimbursement and coverage of medical expenses by insurance companies and the aging of the population are among the factors driving these imaging markets. This report, Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems from Kalorama Information, details these factors and provides 2011 market size and forecast to 2015 for...Published: December 14, 2015 | Price: $175.00 – $350.00
Hologic: Company Profile Hologic: Company Profile examines this leading developer, manufacturer, and supplier of premium diagnostic products, medical imaging systems and surgical products. The company operates four core business units focused on diagnostics, breast health, GYN surgical and skeletal health. Hologic, Inc. is a leading developer, manufacturer and supplier of products dedicated to women’s health. Hologic provides products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, permanent contraception, osteoporosis assessment, preterm...Published: February 22, 2017 | Price: $200.00 – $400.00
Monthly events of note in the in vitro diagnostic industry from Kalorama Information's analysts.Published: March 22, 2017 | Price: $200.00 – $400.00
Kalorama's current trends in the in vitro diagnostic industry.Published: April 24, 2017 | Price: $200.00 – $400.00
A look at key trends in in vitro diagnostics in the month of April 2017.Published: May 26, 2017 | Price: $200.00 – $400.00
This report describes major trends in the in vitro diagnostic industryPublished: August 15, 2017 | Price: $200.00 – $400.00
Coverage of major IVD industry events and trends July 2017.Published: October 19, 2017 | Price: $200.00 – $400.00
New products in IVD, as launched at major diagnostic conventions.Published: May 1, 2009 | Price: $250.00 – $3,395.00
It is commonly asserted that in vitro diagnostics is a recession-proof industry. Kalorama Information's lead diagnostic analyst Shara Rosen tests that assumption and provides strategic conclusions in Shara Rosen's new report In Vitro Diagnostics in a Recessionary Economy. The economic problems that began slowing the U.S. economy keep spreading, with Europe and Japan following America into recession. The US is experiencing high unemployment rate and increased numbers of uninsured workers. But what impact is the downturn having on in vitro...Published: May 1, 2009 | Price: $250.00 – $1,600.00
The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama's lead analyst, Shara Rosen. Regardless of the eventual severity of the epidemic, there will be distinct market impact on both immunoassay and molecular test makers, according to the report. The...Published: November 2, 2015 | Price: $250.00 – $500.00
Roche Diagnostics: Company Profile Roche Diagnostics: Company Profile examines the Swiss global research-based healthcare company. With product sales almost twice that of its nearest competition, Roche is the world's largest supplier of clinical diagnostics products. Roche is as well the global world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche is also the world's largest biotech company, with 14 biopharmaceuticals on the market. Further, Roche's personalized healthcare strategy aims at providing medicines...Published: November 9, 2015 | Price: $250.00 – $500.00
QIAGEN: Company Profile QIAGEN, a leading global provider of sample and assay technologies, markets more than 500 products around the world, selling both consumable kits and automation systems to customers through four customer classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). QIAGEN: Company Profile examines the global healthcare company whose sample technologies isolate and process DNA, RNA and proteins from biological samples such as blood...Published: October 2, 2018 | Price: $250.00 – $500.00
Trends in IVD Fall of 2017Published: December 17, 2015 | Price: $349.30 – $700.00
Point of Care (POC) Urinalysis Testing Market and Urinalysis Drugs of Abuse Testing Market Point of Care (POC) Urinalysis Testing Market and Urinalysis Drugs of Abuse Testing Market examines the urine strip segment of the global POC professional testing and self-testing markets and the urinalysis segment of the POC professional drugs of abuse testing market, including: Selected Dipstick Urinalysis Systems, 2014 Global POC Urine Strip Testing Market Analysis: 2012-2019 POC Urine Strip Self-Testing Market Analysis, 2014 and 2019 POC Urine...Published: June 23, 2017 | Price: $400.00 – $800.00
Published: June 1, 2012 | Price: $495.00 – $990.00
In February and March of 2012, Kalorama Information conducted a survey of 2,000 adults to ask them whether or not they would take a genetic test. This report, Consumer Testing and the Future of DTC Genetic Testing provides those results and compiles surveys from public and private sources to provide the following insights: Have Consumers Used a Self-Test Product? Would They Take a Genetic Test? Are They Concerned About Their Healthcare? What Diseases Are They Most Concerned About?...Published: April 17, 2015 | Price: $499.00 – $1,000.00
The Market for Clinical Chemistry Routine clinical chemistry comprises 30 to 40 tests of substrates, metabolites, electrolytes, blood gases, enzymes and lipids that can be organized into panels for specialty patient investigation and routine patient screening. Common specialty panels include those for renal clearance, liver function, and metabolic status. Clinical chemistries are performed on analyzers with varying levels of automation depending on the test volume run at a particular test site. The market for routine clinical chemistries can be segmented...Published: October 26, 2015 | Price: $499.00 – $1,000.00
Mergers and Acquisitions in the IVD Market Mergers and Acquisitions in the IVD Market documents some 240 acquisitions that have taken place from 2012 to October 2015 in the extremely dynamic IVD industry. And this is likely only a small portion of what is really happening in the market; more deals are still to come. In vitro diagnostic (IVD) companies have been very busy with respect to acquisitions in an attempt to augment market share in an increasingly competitive market....Published: January 12, 2015 | Price: $500.00 – $1,000.00
Abbott Diagnostics: Company Profile Abbott Diagnostics: Company Profile opens with a discussion of top IVD suppliers, market trends, and general size and growth of the IVD market. Kalorama Information's report then focuses on a key company in the in vitro diagnostics (IVD) industry: Abbott Diagnostics. Abbott Laboratories is a global leader in the IVD industry, a global, diversified health care company active in pharmaceuticals, nutritionals, devices and diagnostics. Abbott's diagnostic products’ strength lies in their sheer presence worldwide. The company...Published: January 21, 2015 | Price: $500.00 – $1,000.00
Roche Diagnostics: Company Profile Roche Diagnostics: Company Profile opens with a discussion of top IVD suppliers, market trends, and general size and growth of the IVD market. Kalorama Information's report then focuses on a key company in the in vitro diagnostics (IVD) industry: Roche Diagnostics. Roche is the world's largest supplier of clinical diagnostics products, the world leader in IVD and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic...Published: January 21, 2015 | Price: $500.00 – $1,000.00
Siemens Healthcare: Company Profile Siemens Healthcare: Company Profile opens with a discussion of top IVD suppliers, market trends, and general size and growth of the IVD market. Kalorama Information's report then focuses on a key company in the in vitro diagnostics (IVD) industry: Siemens Healthcare. Siemens Healthcare offers a comprehensive portfolio of medical solutions across the treatment chain – from prevention and early detection to diagnosis, treatment and follow-up care. Siemens is a major supplier of technology to the healthcare...